Jenny Laird, Ph.D., D.Sc. is based at Lilly’s European Headquarters near London, UK. She leads the global Search & Evaluation team in-licensing or acquiring assets and technologies and advancing molecules through discovery and development in collaboration with external partners including venture firms to complement Lilly’s internal R&D efforts in Neuroscience. Prior to joining Lilly in 2012, Dr. Laird held leadership roles of increasing responsibility in drug discovery and development including precision medicine at AstraZeneca and Merck, and as an academic Principal Investigator. Dr. Laird received doctorates from the University of Bristol, UK and the University of Alicante, Spain. She has served on editorial boards of journals in the field of neuropharmacology, and as an honorary Professor of Pharmacology at McGill University, Canada.